Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at the Medicinal Chemistry & CMC Strategy Meeting Europe 2022

Page View:

Medicinal Chemistry & CMC Strategy Meeting Europe 2022 (1).jpgMedicinal Chemistry & CMC Strategy Meeting Europe 2022 is coming! Medicilon is excited to exhibit in the conference. Our European team look forward to meet you in person to discuss how our services and capabilities would support your current research needs and expedite your drug discovery and development programs. 

Organizer: Proventa International

Date: October 12-13, 2022

Location: Zurich, Switzerland


About Medicinal Chemistry & CMC Strategy Meeting Europe 2022

With the growing excitement brought by advances in protein structure prediction, using RNA and small molecules as therapeutic, and drugging the undruggable, we have come a long way despite the implications of the pandemic on industry output. Despite the increased innovation, quality of methods, and techniques geared toward the discovery and optimization, maintaining productivity, a consistent rollout of successful drug candidates, along with unlocking the most favorable targets remain an industry challenge. At Medicinal Chemistry & CMC Strategy Meeting Europe 2022 in Zurich, senior leaders in Medicinal Chemistry will gather for candid and strategic discussions to ensure the most impactful challenges are being addressed and solutions uncovered.

The journey to develop a product, move it towards health authority approval and eventual commercial success can be a long and arduous process. In conjunction, obstacles may impede this journey and risk a product development team’s ability to reach their destination such as pharmaceuticals being denied approval due to the quality of the product and the manufacturing process failing to meet sufficiently high standards. Join the CMC STRATEGY MEETING and address the need to create and implement CMC strategies that ensure the product is high-quality, safe, effective and consistent, as well as approaches to expedite drug development to bring even more products to market.

About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance. Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

Medicinal Chemistry Services

At Medicilon, chemistry and biology are ingrained in every project we undertake. Our medicinal chemistry team is capable of flexibly applying computer chemistry to assist compound design process. In the meantime, we apply advanced drug discovery technologies, including proteolysis-targeting chimera (PROTAC), DNA-encoded chemical library (DEL) and antibody drug conjugation (ADC).

We are also proud of our rich experience in innovative design and patent strategies that complement our technologies. In addition, our responsive project management and effective communication help optimize our project delivery.


Feasibility assessment of new drug targets

High-throughput screening and discovery of active compounds based on  structural design

SAR-based compound synthesis and SAR-based optimization

Establishment of specific compound libraries (establishment of micromolecule compound library)

Rapid synthesis of PROTAC molecules and ADC payloads, as well as lipids, glycolipids, and phospholipids

Screening of new hit compounds from DEL (from active compounds to discovery of lead compounds)

Synthesis, discovery, and optimization of hit compounds

Research on SAR

Computer-aided drug design (CADD)

Processes from optimization of lead compounds to determination of preclinical drug candidates

Patent preparation and application

ELN system records

Multi-parameter lead optimization for desired target molecule profiles (synthesis, discovery, and structural optimization of lead compounds)


Medicilon provides comprehensive pharmaceutical analysis services, including methodology development and verification, analytical testing and release, stability study, scale separation, and CMC filing documents.

CMC services for IND/CTA, NDA/MAA and ANDA filings

High-quality, fast and low-cost one-stop services

One-stop services for drug analysis, research and development, stability, quality control, and CMC regulatory documents

Applicable to domestic and overseas filings

Relevant newsRelevant news